• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

    0.1599 -0.0555 (-25.77%)
    Delayed Quote Updated: 2:54 PM EDT, Oct 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,866,157
    Open 0.1665
    Bid (Size) 0.1593 (500)
    Ask (Size) 0.1600 (6,600)
    Prev. Close 0.2154
    Today's Range 0.1578 - 0.1900
    52wk Range 0.1855 - 23.20
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
    From Sunshine Biopharma Inc.
    Via ACCESS Newswire
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill

    Performance

    52-Week Range 99.3% below 52-week high
    0.1599
    0.1952W Low 23.2052W High
    1 Week 36.5% below 1-week high
    0.191W Low 0.251W High

    Sunshine Biopharma Inc. - Common stock (SBFM) traded between $0.19 and $23.20 over the past 52 weeks and last traded at $0.16, 99.3% below its 52-week high. Over the past week it ranged between $0.19 and $0.25.

    Past 12 Months
    -30.5%
    -82.4%
    -91.2%
    -98.4%
    -98.8%
    -99.2%
    1W -$0.07
    1M -$0.75
    3M -$1.65
    6M -$9.76
    YTD -$12.64
    1Y -$19.04

    SBFM was -99.2% over the past year, -98.4% over six months, -98.8% year to date, -30.5% in the last week.

    12 Months vs Market
    SBFM
    -99.2%
    DIA
    +12.2%
    SPY
    +13.5%
    QQQ
    +15.0%
    IWM
    +11.7%

    Over the past 12 months SBFM returned -99.2% versus DIA (Dow) +12.2%, SPY (S&P 500) +13.5%, QQQ (Nasdaq 100) +15.0% and IWM (Russell 2000) +11.7%.

    Volume & Liquidity 0.52× 3-mo avg
    Today 2,866,157 3-mo avg 5.5M
    1W
    954.4K
    1M
    14.1M
    3M
    5.5M
    6M
    3.6M
    YTD
    2.3M
    1Y
    1.8M

    SBFM most recently traded 2,866,157 shares against a 3-month average daily volume of 5.5M.

    More News

    Read More
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering
    From Sunshine Biopharma Inc.
    Via ACCESS Newswire
    Top stock movements in today's session. ↗
    Via Chartmill
    These stocks are making the most noise in today's session. ↗
    Via Chartmill
    On Thursday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Thursday's session. ↗
    Via Chartmill
    Thursday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
    From Sunshine Biopharma Inc.
    Via ACCESS Newswire
    Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
    Via Chartmill
    Curious about the most active stocks on Wednesday? ↗
    Via Chartmill
    What's going on in today's session ↗
    Via Chartmill
    Monday's session: top gainers and losers ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Monday's session. ↗
    Via Chartmill
    Monday's session: gap up and gap down stocks ↗
    Via Chartmill
    Discover the top movers in Monday's pre-market session. ↗
    Via Chartmill
    News headline image
    Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio
    From Sunshine Biopharma Inc.
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies
    From Sunshine Biopharma Inc.
    Via ACCESS Newswire
    News headline image
    Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions
    From Sunshine Biopharma Inc.
    Via ACCESS Newswire
    News headline image
    A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
    Via FinancialNewsMedia
    News headline image
    A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
    From MarketNewsUpdates.com
    Via GlobeNewswire
    News headline image
    Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer
    From Sunshine Biopharma Inc.
    Via ACCESS Newswire
    News headline image
    Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
    From Sunshine Biopharma Inc.
    Via ACCESS Newswire

    Frequently Asked Questions

    Is Sunshine Biopharma Inc. - Common stock publicly traded?
    Yes, Sunshine Biopharma Inc. - Common stock is publicly traded.
    What exchange does Sunshine Biopharma Inc. - Common stock trade on?
    Sunshine Biopharma Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Sunshine Biopharma Inc. - Common stock?
    The ticker symbol for Sunshine Biopharma Inc. - Common stock is SBFM on the Nasdaq Stock Market
    What is the current price of Sunshine Biopharma Inc. - Common stock?
    The current price of Sunshine Biopharma Inc. - Common stock is 0.1599
    When was Sunshine Biopharma Inc. - Common stock last traded?
    The last trade of Sunshine Biopharma Inc. - Common stock was at 10/22/26 02:54 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.